Wednesday, January 25, 2012
Drug May Slow Early Prostate Cancer: Study
New research suggests that Avodart, a drug used to treat an enlarged prostate gland, may help slow the progression of early stage prostate cancer, reducing the need for aggressive treatment in some men.
Prostate cancer can grow and spread slowly, which is why some men are urged to engage in so-called watchful waiting when the cancer is first diagnosed. Avodart (dutasteride) may help such men feel comfortable with surveillance as opposed to radical treatment, the researchers noted.
The medication does have side effects, however, including reversible breast enlargement and tenderness and some sexual dysfunction.
Some experts have concerns about 5-alpha reductase inhibitors. The U.S. Food and Drug Administration recently issued a warning that men who take these drugs to treat enlarged prostate glands may be at increased risk for high-grade prostate cancer.
Read the full HealthDay report here:
Drug May Slow Early Prostate Cancer
Saturday, January 7, 2012
Don't believe hype about robot prostatectomy: study
Older men considering robotic surgery for prostate cancer shouldn't trust the rosy ads promoting the expensive technology over low-tech surgery.
That's according to a new survey that found complaints about sexual problems and urinary leakage were equally common after the two procedures.
"I wasn't surprised at all," said Dr. Otis Brawley, chief medical officer of the American Cancer Society, who wasn't involved in the study.
"Unfortunately, robotic prostatectomy -- like many things in prostate cancer -- has gotten a lot more hype than it should."
Read the full Reuters reporter here:Don't believe hype about robot prostatectomy
PSA screening doesn't prevent cancer deaths: study
Annual screening for prostate cancer doesn't cut men's chances of dying from the disease, according to the latest results of a large screening trial.
The results support a previous report by the same researchers that found no difference in deaths seven to 10 years after the screening program started.
They are also consistent with recent draft guidelines from the U.S. Preventive Services Task Force recommending that average-risk men not undergo regular PSA screening, according to a researcher who worked on the study.
Read the full Reuters report here
PSA screening doesn't prevent cancer deathsFriday, December 30, 2011
Milk intake in teens tied to later prostate cancer
Older Icelandic men who remember chugging a lot of milk in their teens are three times as likely to be diagnosed with advanced prostate cancer as more-moderate milk drinkers, researchers have found.
"We believe that our data are indeed solid and provide important evidence for the role of adolescence as a 'sensitive period' for prostate cancer development," Johanna Torfadottir, a nutrition scientist and a graduate student at the University of Iceland, told Reuters Health by email.
How much milk men drank had no connection to their risk of early-stage tumors, however. And intake in midlife -- the age group most other studies have focused on -- didn't seem to matter either.
"From these data alone we cannot recommend that teenage boys should chance their dietary habits," she said. "We are only looking at the risk of one disease, prostate cancer, and obviously risks of other conditions, e.g. bone health, need to be considered." "It would be premature to say that drinking milk causes prostate cancer," he told Reuters Health. "You can talk about association, but it is hard to prove causality."
Dr. Matthew Cooperberg, a urologist at the University of California, San Francisco, agreed. He added that people shouldn't be wary of drinking milk.
Read the full Reuters Health report here:
Statins tied to lower risk of fatal prostate cancer
In a new study of middle-aged New Jersey men, taking cholesterol-lowering drugs was linked to a lower chance of dying from prostate cancer.
The findings don't prove that the drugs, called statins, ward off aggressive cancer. But they jibe with previous studies suggesting that getting cholesterol levels under control might help reduce the risk of life-threatening disease, researchers said.
The researchers found that men who died of prostate cancer were half as likely to have taken a statin at any time, and for any duration, than men in the "control" group.
Dr. Stephen Marcella, from the University of Medicine and Dentistry of New Jersey said "I would not tell a person if they don't have a risk of heart disease, (if) they don't have hypertension...to take a statin just to prevent lethal prostate cancer."
The evidence that's effective, he said, just isn't there yet.
And even if statins do turn out to help prevent fatal prostate cancer, researchers said, previous studies have suggested they don't lower a man's risk of getting less aggressive forms of the disease.
Read the Reuters report here:
Statins tied to lower risk of fatal prostate cancer
Friday, December 9, 2011
Study finds impotence risk higher in men taking several drugs
Men taking multiple medications for different health conditions may have a higher risk of erectile dysfunction -- a link that doesn't seem to be explained by the health problems themselves, a new study finds.
Overall, 16 percent of men on no more than two drugs reported moderate ED -- meaning they "sometimes" had trouble getting or maintaining an erection. That compared with 20 percent of men on three to five medications, a quarter of men on six to nine drugs and 31 percent of those on at least 10 drugs.
Not surprisingly, ED was more common in men who were older, heavier, smoked or had health problems like diabetes or high blood pressure. But even when the researchers accounted for that, being on multiple medications was still tied to an increased ED risk.
Senior researcher Dr. Steven J. Jacobsen said that it's possible the drugs themselves could contribute to or worsen ED -- via drug interactions, for instance. But there's no way to tell for sure from these findings.What is clear, he stressed, is that men with erectile problems should not simply stop taking their prescriptions.
Read more details here:
Study finds impotence risk higher in men taking several drugs
Thursday, December 8, 2011
Some men can delay prostate cancer treatment: panel
Men with low-risk prostate cancer may wait to see if their disease progresses before treating it, an independent panel of experts convened by the U.S. National Institutes of Health (NIH) said on Wednesday.
Although this is almost 'common knowledge' these days, it's nice to see the NIH adding it's weight to the argument.
Read the full article here:
Some men can delay prostate cancer treatment